What is CBCV (Cannabichromevarin)

Cannabichromevarin (CBCV) first came to limelight in 1975 when Thailand researchers at the University of Nagasaki isolated the compound from a cannabis plant. However, not much research has been conducted on the compound since its discovery.

Actually there is not much information to give concerning the properties of CBCV due to the restrictions on marijuana research. However, there is some knowledge that may be used to predict its effect on the human body.

The concentration of CBCV in cannabis plants is much lower compared to cannabidiol (CBD) and tetrahydrocannabinol (THC). CBCV is related to cannabichromene (CBC), a compound that appears in smaller amounts than the two major ones. The chemical structure of CBCV is similar to that of CBC but much shorter. CBCV can rightly be described as a propyl cannabinoid, meaning that its molecular structure contains a propyl chain. The molecular formula for this compound is C19H26O2.

CBC (Cannabichromene)

Cannabichromene (CBC),  is one of the cannabinoids that found in the Cannabis plant and is therefore a phytocannabinoid. 

It bears structural similarity to the other natural cannabinoids, including  tetrahydrocannabinol (THC), tetrahydrocannabivarin (THCV), cannabidiol (CBD), and cannabinol (CBN), among others.

CBC and its derivatives are as abundant as cannabinols in cannabis.It is not scheduled by the Convention on Psychotropic Substances.

Cannabichromene was discovered in 1966 by Gaoni and Mechoulam on one hand and almost simultaneously by Claussen on the other, although since then little research has been carried out on this cannabinoid, with THC and CBD being the protagonists of the majority of subsequent studies. 

However, as we will see below, today there is a growing body of evidence demonstrating the tremendous therapeutic potential of this cannabinoid, especially in combination with other compounds in what is often referred to as an "ensemble effect of cannabinoids".

"ECH announces plans to open first UK medical cannabis clinics"

European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions

The clinics, which will open this spring, will be the first in the UK to offer cannabis-based therapy and prescription cannabiniods to patients suffering from chronic pain conditions including arthritis, fibromyalgia, nerve conditions, muscle cramps (spasticity); treating neurological conditions such as epilepsy, multiple sclerosis, Alzheimer’s and Parkinson’s disease; and addressing psychiatric problems such as depression, anxiety and post-traumatic stress disorder (PTSD).

The first clinic will open at The Beeches Consulting Centre in Manchester in March and will be led by Dr David McDowell, a Consultant in Pain Management who issued the first prescription for medical cannabis in December.

Clinics will then open in London across multiple disciplines including neurology and psychiatry in addition to chronic pain, on Harley Street, and in Birmingham later this spring.

Woman killed by 'THC overdose' in US, coroner claims...???

According to an article on Independent.co.uk, a US coroner has stood by his conclusion that a woman died of an overdose of THC...

So lets see what exactly says the article... Is this true or some people still hunting witches...????

In what would ostensibly be the first confirmed case in the country, coroner Dr Christy Montegut, of St John the Baptist Parish in Louisiana, said an unnamed 39-year-old woman died in February after vaping THC oil. 

“It looked like it was all THC because her autopsy showed no physical disease or afflictions that were the cause of death. There was nothing else identified in the toxicology — no other drugs, no alcohol. There was nothing else,” Dr Montegut told the New Orleans Advocate newspaper last month. 

CBGA (Cannabigerolic Acid)

 "The stem cell of cannabis"

Cannabigerolic acid is one of the many phytocannabinoids within the cannabis plant. Many phytocannabinoids  have acidic precursors.

To recap really quickly,  these acidic precursors  
turn into a subsequent cannabinoid through a process known as decarboxylation.  


Decarboxylation happens through various forms of heat application and is a fancy science word for when something loses a molecule of carbon dioxide. This heat application can include solar heat or directly applied heat as with cooking or smoking.  

But what makes cannabigerolic acid (CBGa) so special? Is it not just another acidic precursor? Aside from being a precursor for cannabigerol, it is also the precursor for a handful of other acidic precursors including THCA, CBDA and CBCA. It is crucial in creating common cannabinoids like CBC and THC. This is why some cannabis enthusiasts refer to it as the “stem cell” of cannabis, given its transformative nature.